Yahoo奇摩 網頁搜尋

登入

搜尋結果

  1. www.cap.org › protocols-and-guidelines › cap-guidelinesCAP Guidelines | College of American Pathologists

    Evidence-based Guidelines (EBGs) The Center guidelines help pathologists and other clinicians: Make more informed decisions about diagnosis and optimal treatment. Place emphasis on the pathologist's role to the center of patient care. The guideline principles follow the National Academy of Medicine's standards, and we develop evidence-based ...

  2. 頭條新聞

    檢視全部

  3. www.cap.org › protocols-and-guidelines › cap-guidelinesUniform Labeling of Blocks and Slides in Surgical Pathology ...

    Brown RW, Della Speranza V, Alvarez JO, et al. Uniform labeling of blocks and slides in surgical pathology: guideline from the College of American Pathologists Pathology and Laboratory Quality Center and the National Society for Histotechnology. Arch Pathol Lab Med. 2015;139 (12):1515-24. The College of American Pathologists is the world's ...

  4. www.cap.org › protocols-and-guidelines › current-capPD-L1 and TMB Testing of Patients With Lung Cancer for ...

    2024年4月16日 · Six evidence-based recommendations for PD-L1 and TMB testing in the clinical setting are published in the “ PD-L1 and TMB Testing of Patients with Lung Cancer for Selection of Immune Checkpoint Inhibitor Therapies: Guideline From the College of American Pathologists, Association for Molecular Pathology, International Association for the Study ...

  5. www.cap.org › protocols-and-guidelines › cap-guidelinesMolecular Testing Guideline for the Selection of Lung Cancer ...

    • Background
    • Guideline Information
    • Guideline Tools and Resources

    The 2018 "Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment with Targeted Tyrosine Kinase Inhibitors (TKI)" sets evidence-based standards for clinical molecular testing of non-small cell lung cancers (NSCLC) that effectively guides targeted therapy and treatment. We followed up on our 2013 evidence-based gu...

    在「cap.org」查看更多資訊

    Guideline status: In Review
    Originally Published: June 2013
    Update published online ahead of print:January 22, 2018
    Published: March 2018

    在「cap.org」查看更多資訊

    Download the following 2018 tools and resources to help implement the guideline: 1. Summary of Recommendations(PDF, 204 KB) 2. Methodology Supplement(PDF, 796 KB) 3. Teaching Presentation(PDF, 687 KB) 4. Frequently Asked Questions(PDF, 305 KB) 5. Infographic(PDF, 1.6 MB) 6. Webinar

    在「cap.org」查看更多資訊

  6. www.cap.org › laboratory-improvement › proficiency-testingFrequently Asked Questions - CVL | College of American ...

    Home. Laboratory Improvement. Proficiency Testing. Calibration Verification/Linearity (CVL) Frequently Asked Questions - CVL.

  7. www.cap.org › protocols-and-guidelines › cap-guidelinesMolecular Biomarkers for the Evaluation of Colorectal ...

    This thorough set of recommendations is intended to streamline processes and contribute to improving patient outcomes. The evidence-based clinical practice guideline, " Molecular Biomarkers for the Evaluation of Colorectal Carcinoma: Guideline From the American Society for Clinical Pathology , the College of American Pathologists, the ...

  8. www.cap.org › member-resources › councils-committeesFrequently Asked Questions from Immunohistochemistry ...

    Frequently Asked Questions from Immunohistochemistry Laboratories. Maintaining and expanding a test menu in immunohistochemistry can be complex. The following FAQs will address issues related to validation of tests that are new to a laboratory, as well as potential responses to test performance monitoring, especially in the setting of ...